210 related articles for article (PubMed ID: 33050864)
21. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
[TBL] [Abstract][Full Text] [Related]
22. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.
Uddin MS; Al Mamun A; Kabir MT; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
Mol Neurobiol; 2021 Jan; 58(1):281-303. PubMed ID: 32935230
[TBL] [Abstract][Full Text] [Related]
23. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
[TBL] [Abstract][Full Text] [Related]
24. Profiling donepezil template into multipotent hybrids with antioxidant properties.
Mezeiova E; Spilovska K; Nepovimova E; Gorecki L; Soukup O; Dolezal R; Malinak D; Janockova J; Jun D; Kuca K; Korabecny J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):583-606. PubMed ID: 29529892
[TBL] [Abstract][Full Text] [Related]
25. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
[TBL] [Abstract][Full Text] [Related]
26. Natural antioxidants in Alzheimer's disease.
Mancuso C; Bates TE; Butterfield DA; Calafato S; Cornelius C; De Lorenzo A; Dinkova Kostova AT; Calabrese V
Expert Opin Investig Drugs; 2007 Dec; 16(12):1921-31. PubMed ID: 18042001
[TBL] [Abstract][Full Text] [Related]
27. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
[TBL] [Abstract][Full Text] [Related]
28. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
[TBL] [Abstract][Full Text] [Related]
29. Chemical Constituents and their Antioxidant, Anti-Inflammatory and Anti-Acetylcholinesterase Activities from Pholidota cantonensis.
Liu L; Zou M; Zeng K; Ye X; Wang R; Wang W; Zhang X
Plant Foods Hum Nutr; 2021 Mar; 76(1):105-110. PubMed ID: 33620638
[TBL] [Abstract][Full Text] [Related]
30. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
31. N-Substituted Aryl Sulphonamides as Potential Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
Masand N; Gupta SP; Khosa RL
Curr Comput Aided Drug Des; 2018; 14(4):338-348. PubMed ID: 29866012
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
Yang A; Yu Q; Ju H; Song L; Kou X; Shen R
Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
[TBL] [Abstract][Full Text] [Related]
33. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
[TBL] [Abstract][Full Text] [Related]
34. Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.
Marotta G; Basagni F; Rosini M; Minarini A
Molecules; 2020 Sep; 25(17):. PubMed ID: 32887400
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.
Kou X; Song L; Wang Y; Yu Q; Ju H; Yang A; Shen R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126927. PubMed ID: 31901382
[TBL] [Abstract][Full Text] [Related]
36. Biological evaluation of 7-O-amide hesperetin derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
Wu M; Zhu X; Zhang Y; Wang M; Liu T; Han J; Li J; Li Z
Chem Biol Interact; 2021 Jan; 334():109350. PubMed ID: 33307048
[TBL] [Abstract][Full Text] [Related]
37. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
[TBL] [Abstract][Full Text] [Related]
38. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
39. New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease.
Cai R; Wang LN; Fan JJ; Geng SQ; Liu YM
Bioorg Chem; 2019 Dec; 93():103328. PubMed ID: 31600664
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Potential of Ferulic Acid in Alzheimer's Disease.
Turkez H; Arslan ME; Barboza JN; Kahraman CY; de Sousa DP; Mardinoğlu A
Curr Drug Deliv; 2022; 19(8):860-873. PubMed ID: 34963433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]